Valent BioSciences Corporation announced it has filed worldwide patent applications claiming beneficial health effects of abscisic acid (S-ABA) in humans and animals. S-ABA is a naturally occurring substance found in all plants, including fruits and vegetables.
The patent applications disclose data that could support further research for S-ABA as a therapeutic treatment or dietary supplement.
'VBC is the only global manufacturer and marketer of S-ABA and we're excited to be actively exploring potential commercial opportunities for the molecule in a variety of markets,' said Dr. Warren E. Shafer, Valent BioSciences' Vice President of Global Research & Development and Regulatory Affairs.
The filings are part of a series of global patents and patent applications related to S-ABA sought by the Illinois-based biotechnology company, which has commercialized two S-ABA products for crop use in the last three years. ProTone[R] Plant Growth Regulator was launched in 2009 to enhance color in table grapes, while BioNikTM Plant Growth Regulator is being launched in 2012 as a seed treatment to extend the window of pollen shed in hybrid corn seed production. About Valent BioSciences Corporation: Headquartered in Libertyville, IL, Valent BioSciences Corporation is a subsidiary of Tokyo-based Sumitomo Chemical Company. Valent BioSciences is the worldwide leader in the development, manufacturing and commercialization of biorational products, with sales in over 90 countries around the world. VBC is an ISO 9001:2008 Certified Company. For additional information, visit the company's website at www.valentbiosciences.com.
Keywords: Chemistry, Legal Issues, Animal Health.
This article was prepared by Veterinary Week editors from staff and other reports. Copyright 2012, Veterinary Week via VerticalNews.com.
